Morgan Stanley: Eni leads European oil majors in production growth outlook
Morgan Stanley analyzed production data from approximately 4,000 oil and gas fields to assess the growth outlook for European energy majors through 2030. The analysis shows aggregate production growth for the sector improved to 2.9% annually for 2025-2030, up from 1.2% in the previous year’s forecast. Rolling four-year forward production increased 8.3%. Eni emerged with ...
On Monday, September 7, several Tata Group companies, four railway stocks, two shipping sector entities, and three major pharmaceutical firms will remain under scrutiny. Tata Consultancy Services secured land for a large-scale AI data centre campus in Hyderabad, with an investment of up to Rs 70,000 crore. Former CEO Patrick Raymon McGoldrick sold shares worth nearly Rs 165 crore, reducing his stake to 0.62 percent.
Tata Motors launched a tender offer to acquire Iveco Group for EUR 14.10 per share, valuing the company at approximately EUR 3.82 billion. Adani Defence & Aerospace signed a five-year agreement to supply ammunition for AK-203 assault rifles in India, creating an integrated domestic supply chain. Rail Vikas Nigam received a Letter of Award for constructing a permanent siding in Bihar's Buxar Thermal Power Project.
Texmaco Rail & Engineering Ltd received two domestic orders worth Rs 131.36 crore. Airfloa Rail Technology Ltd received a Letter of Acceptance for an order worth Rs 31.08 crore. Kalind Ltd initiated an Equipment Rental and Services Agreement with AME SAKI Mining and Construction Limited in Ghana. Mazagon Dock Shipbuilders received an order for AI-based Comprehensive Infrasecure Project for Rs 117.99 crore.
Transworld Shipping Lines Ltd acquired a marine vessel named Valsamitis for $11,750,000. Som Distilleries and Breweries Ltd approved raising funds through the issuance of up to 32,12,955 convertible equity warrants to a promoter. Zydus Pharmaceuticals USA Inc. settled a lawsuit for $5.9 million. Cohance Lifesciences received a Form FDA 483 containing four observations after an FDA inspection.
Written by urgent.news from Hindu BusinessLine's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.